F. Perry Wilson, MD, MSCE, shares insights from a review of recent study results published in the New England Journal of Medicine examining duty-hours rules at 63 residency…
NEW YORK (Reuters Health) – When considering risk factors for venous thromboembolism, recent lengthy travel does not appear to be a significant candidate, according to results of a…
NEW YORK (Reuters Health) – Even though they are at increased risk of invasive cervical cancer, nearly one in four HIV-positive women in the US who were recently…
NEW YORK (Reuters Health) – In general, bariatric surgery is associated with a low risk of death and other adverse events in the 30-day postoperative period, according to…
NEW YORK (Reuters Health) – Upon starting an antipsychotic drugs, older patients with diabetes are prone to episodes of hyperglycemia severe enough to require hospitalization, Canadian researchers report…
NEW YORK (Reuters Health) – Nearly one out of six patients in China who is prescribed an antihypertensive agent will discontinue treatment within 6 months. Multiple factors affect…
NEW YORK (Reuters Health) – In patients with metastatic renal cell carcinoma, first-line treatment with interferon (IFN)-alpha plus sunitinib or bevacizumab has “clinically relevant and statistically significant” survival…
NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in…
NEW YORK (Reuters Health) – In patients with pulmonary thromboemboli, the presence of a mobile right cardiac thrombus (MRCT) is strongly linked to death, new research shows. Although…
NEW YORK (Reuters Health) – Sterile water injected lateral to the lumbosacral spine in women with severe low back pain during labor substantially reduces pain and decreases the…
NEW YORK (Reuters Health) – Adding hormone therapy to radiotherapy for locally advanced prostate cancer reduces disease recurrence and prolongs survival, according to a report in the August…
